There have been no open-market insider trades at Trulieve Cannabis Corp. in the last 12 months.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
There have been no open-market insider trades at Trulieve Cannabis Corp. in the last 12 months.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Thronson Susan | Director | Buy | 3,968 | $6.30 | $25K | SEC |
| Aug 13, 2025 | May Richard S. | Director | Buy | 1,610 | $6.05 | $10K | SEC |
| Dec 13, 2024 | Getman Wes | CFO | Buy | 9,500 | $4.91 | $47K | SEC |
| Nov 21, 2024 | Healy Peter | Director | Buy | 8,130 | $6.05 | $49K | SEC |
| Nov 21, 2024 | MORREAU JANE C | Director | Buy | 1,235 | $6.06 | $7K | SEC |
| Nov 21, 2024 | May Richard S. | Director | Buy | 1,160 | $6.05 | $7K | SEC |
| Nov 21, 2024 | MILLNER THOMAS L | Director | Buy | 8,000 | $6.12 | $49K | SEC |
| Nov 21, 2024 | Thronson Susan | Director | Buy | 3,968 | $6.30 | $25K | SEC |
| Nov 21, 2024 | Collins Gina | Executive Officer | Buy | 1,250 | $6.37 | $8K | SEC |
| Nov 19, 2024 | Beshears Thad | Director | Buy | 7,500 | $6.65 | $50K | SEC |
| Nov 18, 2024 | Rivers Kim A. | CEO | Buy | 7,400 | $6.65 | $49K | SEC |
| Nov 14, 2024 | Powers Eric | Executive Officer | Buy | 1,000 | $6.10 | $6K | SEC |
| Nov 14, 2024 | Jhala Nilyum | Executive Officer | Buy | 1,500 | $6.98 | $10K | SEC |
| Nov 14, 2024 | Jhala Nilyum | Executive Officer | Buy | 2,000 | $5.70 | $11K | SEC |
| Nov 14, 2024 | Jhala Nilyum | Executive Officer | Buy | 2,500 | $6.32 | $16K | SEC |
There were no open-market insider trades in TRUL in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in TRUL were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).